Page last updated: 2024-11-06

lysergic acid diethylamide and Atrophy

lysergic acid diethylamide has been researched along with Atrophy in 1 studies

Lysergic Acid Diethylamide: Semisynthetic derivative of ergot (Claviceps purpurea). It has complex effects on serotonergic systems including antagonism at some peripheral serotonin receptors, both agonist and antagonist actions at central nervous system serotonin receptors, and possibly effects on serotonin turnover. It is a potent hallucinogen, but the mechanisms of that effect are not well understood.
lysergic acid diethylamide : An ergoline alkaloid arising from formal condensation of lysergic acid with diethylamine.

Atrophy: Decrease in the size of a cell, tissue, organ, or multiple organs, associated with a variety of pathological conditions such as abnormal cellular changes, ischemia, malnutrition, or hormonal changes.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Campbell, AM1
Evans, M1
Thomson, JL1
Williams, MJ1

Other Studies

1 other study available for lysergic acid diethylamide and Atrophy

ArticleYear
Cerebral atrophy in young cannabis smokers.
    Lancet (London, England), 1971, Dec-04, Volume: 2, Issue:7736

    Topics: Adolescent; Adult; Amphetamines; Atrophy; Brain Diseases; Cerebral Ventricles; Cerebral Ventriculogr

1971